Your browser doesn't support javascript.
loading
The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors.
Brunner, Philippe; Jörg, Ann-Catherine; Glatz, Katharina; Bubendorf, Lukas; Radojewski, Piotr; Umlauft, Maria; Marincek, Nicolas; Spanjol, Petar-Marko; Krause, Thomas; Dumont, Rebecca A; Maecke, Helmut R; Müller-Brand, Jan; Briel, Matthias; Schmitt, Anja; Perren, Aurel; Walter, Martin A.
Affiliation
  • Brunner P; Institute of Pathology, University Hospital Basel, CH, Basel, Switzerland.
  • Jörg AC; Institute of Nuclear Medicine, University Hospital Basel, CH, Basel, Switzerland.
  • Glatz K; Institute of Nuclear Medicine, University Hospital Basel, CH, Basel, Switzerland.
  • Bubendorf L; Institute of Pathology, University Hospital Basel, CH, Basel, Switzerland.
  • Radojewski P; Institute of Pathology, University Hospital Basel, CH, Basel, Switzerland.
  • Umlauft M; Institute of Nuclear Medicine, University Hospital Bern, CH, 3010, Bern, Switzerland.
  • Marincek N; Institute of Nuclear Medicine, University Hospital Bern, CH, 3010, Bern, Switzerland.
  • Spanjol PM; Institute of Nuclear Medicine, University Hospital Basel, CH, Basel, Switzerland.
  • Krause T; Institute of Nuclear Medicine, University Hospital Bern, CH, 3010, Bern, Switzerland.
  • Dumont RA; Institute of Nuclear Medicine, University Hospital Bern, CH, 3010, Bern, Switzerland.
  • Maecke HR; Institute of Nuclear Medicine, University Hospital Bern, CH, 3010, Bern, Switzerland.
  • Müller-Brand J; Institute of Nuclear Medicine, University Hospital Bern, CH, 3010, Bern, Switzerland.
  • Briel M; Division of Radiological Chemistry, University Hospital Basel, Basel, Switzerland.
  • Schmitt A; Institute of Nuclear Medicine, University Hospital Basel, CH, Basel, Switzerland.
  • Perren A; Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, CH, Switzerland.
  • Walter MA; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada.
Eur J Nucl Med Mol Imaging ; 44(3): 468-475, 2017 Mar.
Article in En | MEDLINE | ID: mdl-27539020
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Octreotide / Neuroendocrine Tumors / Radiopharmaceuticals Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2017 Type: Article Affiliation country: Switzerland
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Octreotide / Neuroendocrine Tumors / Radiopharmaceuticals Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2017 Type: Article Affiliation country: Switzerland